1. Home
  2. DK vs TVTX Comparison

DK vs TVTX Comparison

Compare DK & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

N/A

Current Price

$63.43

Market Cap

4.7B

Sector

Energy

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$49.77

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DK
TVTX
Founded
2001
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.7B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
DK
TVTX
Price
$63.43
$49.77
Analyst Decision
Buy
Strong Buy
Analyst Count
14
15
Target Price
★ $85.21
$75.14
AVG Volume (30 Days)
1.5M
★ 2.3M
Earning Date
11-06-2026
11-02-2026
Dividend Yield
★ 1.92%
N/A
EPS Growth
★ 95.67
92.89
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.02
$55.24
Revenue Next Year
N/A
$43.78
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.85
$22.59
52 Week High
$82.27
$68.73

Technical Indicators

Market Signals
Indicator
DK
TVTX
Relative Strength Index (RSI) 36.36 41.05
Support Level $58.20 $49.46
Resistance Level $68.85 $59.93
Average True Range (ATR) 4.50 2.73
MACD -1.47 0.28
Stochastic Oscillator 20.11 50.89

Price Performance

Historical Comparison
DK
TVTX

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has three segments: Refining segment and Logistics segment and retail segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: